LATIN AMERICA AMNIOTIC MEMBRANE MARKET 2022-2028
MARKET OUTLOOK
Triton’s research report infers that the amniotic membrane market in Latin America is expected to showcase progress at a CAGR of 6.14% during the forecast period 2022-2028. Mexico, Brazil, and Rest of Latin America shape the reviewed market in the region.
In Mexico, an amniotic membrane bank follows a comprehensive protocol for donor selection, tissue harvesting, storage, and distribution. The country has witnessed significant growth in the use of amniotic membrane for treating various conditions, including corneal ulcers, conjunctival surface repair, neoplasms, and epithelial defects. Furthermore, they are widely used across hospitals in the ophthalmology branch of medicine. The rising use of amniotic membrane has helped hospitals offer better treatments and surgeries. Therefore, as mentioned above, these factors widely support the growth of the amniotic membrane market within Mexico.
On the other hand, a lyophilized amniotic membrane patch is used as a replacement of tamponades in treating retinal detachment. Moreover, the use of a lyophilized amniotic membrane is widely studied, showcasing promising results. Besides, the lyophilized amniotic membrane seals retinal tear effectively until chorioretinal adhesion is settled, overcoming any risks. The growing demand is also owing to its beneficial properties, such as regenerative and anti-inflammatory. Thus, all these factors play a key role in augmenting the amniotic membrane market’s growth across Argentina.
COMPETITIVE OUTLOOK
The prominent companies in the amniotic membrane market consist of Bio Tissue Inc, MiMedx, Amino Technology LLC, Labtician Ophthalmics Inc, Sky Biologics LLC, and Smith and Nephew Plc.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook